Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Health-Related Quality of Life Profile and Symptom Burden of Patients with Aggressive B-Cell Lymphomas Just before CAR-T-Cell Therapy: A Real-World Study By the Gimema

Blood (2023) 142 (Supplement 1): 7384.

https://doi.org/10.1182/blood-2023-180012

Published: 2023

Journal Articles

Long-Term Analysis of an Open-Label, Multicentre, Randomized Phase 3 Trial Comparing Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine As a Preparative Regimen for Allogeneic Stem-Cell Transplantation in Patients with Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 7667–7669.

https://doi.org/10.1182/blood-2022-162472

Published: 2022

Journal Articles

Anakinra for Treatment and Prevention of CAR-T Neurotoxicity: A Systematic Review of Evidence to Inform SIE-GITMO-Sidem Guidelines

Monia Marchetti, Annalisa Chiappella, Maria Guarino, Giorgia Gobbi, Massimo Martino, Andrés J.M. Ferreri, Luca Fumagalli, Riccardo Saccardi, Mauro Montanari, Maurizio Martelli, Francesco Merli, Pier Luigi Zinzani

Blood (2022) 140 (Supplement 1): 5056–5057.

https://doi.org/10.1182/blood-2022-165125

Published: 2022

Journal Articles

Real-Life CAR-T Cell Treatment in Large B-Cell Lymphomas Indicates That Axi-Cel and Tisa-Cel Have Similar Outcomes, but Long-Term Cytopenia Is an Emerging Problem

Blood (2021) 138 (Supplement 1): 3867.

https://doi.org/10.1182/blood-2021-154037

Published: 2021

Journal Articles

Outcome of Two Loci Mismatched (≤6/8) Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia: ALWP of the EBMT Study

Arnon Nagler, MD MSc, Myriam Labopin, MD, Benedetto Bruno, MD, Alessandro Rambaldi, MD, Pietro Pioltelli, MD, Giorgio La Nasa, MD, Gerard Socie, MD PhD, Stephan Mielke, MD, Marco Ruggeri, Riccardo Saccardi, MD, Uwe Platzbecker, MD, Jürgen Finke, MD, Annalisa Ruggeri, MD, Bipin N. Savani, MD, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 4604.

https://doi.org/10.1182/blood-2019-122090

Published: 2019

Journal Articles

BEAM Vs Cyclophosphamide-Based Conditioning Regimen in Aggressive Multiple Sclerosis: A Retrospective Analysis of European Blood and Marrow Transplantation Society

Riccardo Saccardi, MD, Manuela Badoglio, Joachim Burman, Grzegorz Helbig, Majid A. Kazmi, FRCP, Giovanni Mancardi, Stephan Mielke, MD, John Moore, MDFRACP,FRCPA, Paolo Muraro, Jaime Sanz, MD PhD, Basil Sharrack, Marek Smilowski, Maria Pia Sormani, John A Snowden, MD PhD

Blood (2019) 134 (Supplement_1): 3313.

https://doi.org/10.1182/blood-2019-125233

Published: 2019

Journal Articles

FLT3 and NPM1 Are Powerful Determinants of Outcome in Acute Myeloid Leukemia Patients Treated with Autologous Stem Cell Transplantation: An Analysis By the Acute Leukemia Working Party of the EBMT

Roni Shouval, MD PhD, Myriam Labopin, MD, David Bomze, MSc, Gabriela M Baerlocher, Robin Foà, MD, Didier Blaise, Mathias Haenel, MD, Edouard Forcade, MD, Anne Huynh, MD, Riccardo Saccardi, MD, Giuseppe Milone, MDPhD, Tsila Zuckerman, MD, Péter Reményi, MD, Jordi Esteve, MD PhD, Norbert Claude Gorin, MDPhD, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2018) 132 (Supplement 1): 609.

https://doi.org/10.1182/blood-2018-99-111614

Published: 2018

Journal Articles

Permissive HLA-DPB1 Mismatch and Survival after Unrelated Donor Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Comparative Analysis of Different Immunogenetic Models on 422 Patients from GITMO and IBMDR

Francesca Lorentino, Nicoletta Sacchi, PhD BSc, Elena Oldani, MSc, Valeria Miotti, Alessandra Picardi, Anna Maria Gallina, Paolo Bernasconi, Riccardo Saccardi, MD, Lucia Farina, MD, Fabio Benedetti, Francesca Patriarca, MD, Michela Cerno, Benedetto Bruno, Alessandro Rambaldi, MD, Fabio Ciceri, MD, Katharina Fleischhauer, Luca Vago, MD PhD, Francesca Bonifazi

Blood (2018) 132 (Supplement 1): 482.

https://doi.org/10.1182/blood-2018-99-115216

Published: 2018

Journal Articles

Outcomes of Graft Failures after Umbilical Cord Blood Transplantation in Acute Leukemia: A Study from Eurocord and the Acute Leukemia Working Party of the EBMT

Frederic Baron, Annalisa Ruggeri, MD, Eric Beohou, Myriam Labopin, MD PhD, Mohamad Mohty, MD PhD, Jaime Sanz, Riccardo Saccardi, Patrice Chevallier, MD, Mauricette Michallet, MD PhD, Jean-Henri Bourhis, Christelle M Ferra Coll, William Arcese, MD, Eliane Gluckman, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 661.

https://doi.org/10.1182/blood.V130.Suppl_1.661.661

Published: 2017

Journal Articles

Impact of CTLA4 genotype and other immune response gene polymorphisms on outcomes after single umbilical cord blood transplantation

Blood (2017) 129 (4): 525–532.

https://doi.org/10.1182/blood-2016-06-722249

Published: 2017

Includes: Supplemental data

Journal Articles

Impact of CTLA4 Genotype and Other Immune Response Gene Polymorphisms on Outcomes after Umbilical Cord Blood Transplantation - a Eurocord, CBC-Ctiwb-EBMT, Netcord and FMRP-USP Study

Blood (2015) 126 (23): 400.

https://doi.org/10.1182/blood.V126.23.400.400

Published: 2015

Journal Articles

Flow Cytometry Assessment of CD34 + Viability in Thawed Cord Blood Units: A Multi-Center Eurocord and Netcord Study

Riccardo Saccardi, MD, Carmen Azqueta, Lara Ballerini, PhD, Etienne Baudoux, MD, Simone Dal Pozzo, Gomez Susana, PhD, Gesine Kogler, Prof. MDPhD, Francesco Lanza, MD, Manuele Ongari, Sergio Querol, MD PhD, Teja Falk Radke, PhD, Vanderson Rocha, MD PhD, Annalisa Ruggeri, MD PhD, Serena Urbani, Eliane Gluckman, MD

Blood (2014) 124 (21): 851.

https://doi.org/10.1182/blood.V124.21.851.851

Published: 2014

Journal Articles

Fully Automated Washing of Cryopreserved Peripheral Blood Stem Cells (PBSC): Results of a Prospective, Multicenter, Clinical Trial.

Riccardo Saccardi, MD, Miguel Blanquer, MD, Margherita Boieri, Christoph Bucher, MD, Christian Chabannon, MD, PhD, Simone Dal Pozzo, Benjamin Esterni, Ph.D., Francesco Lanza, MD, Claude Lemarie, Maria Dolores Lopez Lucas, Doris Loutan, Jose M Morelada Jimenez, Andre Tichelli, MD, Boris Calmels

Blood (2012) 120 (21): 3164.

https://doi.org/10.1182/blood.V120.21.3164.3164

Published: 2012

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation Versus Intravenous Pulse Therapy Cyclophosphamide for Severe or Rapidly Progressive Systemic Sclerosis, the Astis Trial

Blood (2012) 120 (21): 964.

https://doi.org/10.1182/blood.V120.21.964.964

Published: 2012

Journal Articles

Determining Late Engraftment Following Single Cord, Unrelated Transplantation: An Analysis of the Eurocord Registry

Riccardo Saccardi, MD, Myriam Labopin, MD, Annalisa Ruggeri, MD, Chantal Kenzey, Wagnara Chaves, MD, Renato Cunha, MD, Eliane Gluckman, MD, Vanderson Rocha, MD, PhD

Blood (2011) 118 (21): 650.

https://doi.org/10.1182/blood.V118.21.650.650

Published: 2011

Journal Articles

Autologous Hematopotoietic Stem Cell Transplantation in Multiple Sclerosis with An Intermediate Intensity Conditioning Regimen: The Italian Multi-Centre Experience

Blood (2011) 118 (21): 334.

https://doi.org/10.1182/blood.V118.21.334.334

Published: 2011

Journal Articles

Endothelial progenitor cell–dependent angiogenesis requires localization of the full-length form of uPAR in caveolae

Francesca Margheri, Anastasia Chillà, Anna Laurenzana, Simona Serratì, Benedetta Mazzanti, Riccardo Saccardi, Michela Santosuosso, Giovanna Danza, Niccolò Sturli, Fabiana Rosati, Lucia Magnelli, Laura Papucci, Lido Calorini, Francesca Bianchini, Mario Del Rosso, Gabriella Fibbi

Blood (2011) 118 (13): 3743–3755.

https://doi.org/10.1182/blood-2011-02-338681

Published: 2011

Journal Articles

Dendritic cells with lymphocyte-stimulating activity differentiate from human CD133 positive precursors

Maria Ida Bonetti, Laura Pieri, Lola Domenici, Serena Urbani, Giovanni Romano, Alessandra Aldinucci, Clara Ballerini, Monica Monici, Riccardo Saccardi, Venere Basile, Alberto Bosi, Paolo Romagnoli

Blood (2011) 117 (15): 3983–3995.

https://doi.org/10.1182/blood-2010-08-299735

Published: 2011

Journal Articles

Prophylaxis and Treatment of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation: A Survey on Center Strategies by the European Group for Blood and Marrow Transplantation (EBMT)

Tapani Ruutu, MD, Anja van Biezen, StatAnalyst, Bernd Hertenstein, MD, Anja Henseler, MSc, Laurent Garderet, MD, Jakob Passweg, MD, MS, Vanderson Rocha, MD, Riccardo Saccardi, MD, Anna Sureda, MD, PhD, Alois Gratwohl, MD, Dietger Niederwieser, MD, Theo de Witte, MD

Blood (2010) 116 (21): 1261.

https://doi.org/10.1182/blood.V116.21.1261.1261

Published: 2010

Journal Articles

Cytomegalovirus (CMV) and Epstein-Barr Virus (EBV) Reactivation In Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Severe Multiple Sclerosis (MS).

Riccardo Saccardi, Filippo Fani, Annamaria Repice, Pietro Maggi, Massimo Di Gioia, Elisabetta Andreoli, Alberto Bosi, Stefano Guidi, Antonella Gozzini, Luca Massacesi, Maria Pia Amato, Chiara Nozzoli

Blood (2010) 116 (21): 4537.

https://doi.org/10.1182/blood.V116.21.4537.4537

Published: 2010

NARROW

Health-Related Quality of Life Profile and Symptom Burden of Patients with Aggressive B-Cell Lymphomas Just before CAR-T-Cell Therapy: A Real-World Study By the Gimema

Long-Term Analysis of an Open-Label, Multicentre, Randomized Phase 3 Trial Comparing Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine As a Preparative Regimen for Allogeneic Stem-Cell Transplantation in Patients with Acute Myeloid Leukemia

Anakinra for Treatment and Prevention of CAR-T Neurotoxicity: A Systematic Review of Evidence to Inform SIE-GITMO-Sidem Guidelines

Real-Life CAR-T Cell Treatment in Large B-Cell Lymphomas Indicates That Axi-Cel and Tisa-Cel Have Similar Outcomes, but Long-Term Cytopenia Is an Emerging Problem

Outcome of Two Loci Mismatched (≤6/8) Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia: ALWP of the EBMT Study

BEAM Vs Cyclophosphamide-Based Conditioning Regimen in Aggressive Multiple Sclerosis: A Retrospective Analysis of European Blood and Marrow Transplantation Society

FLT3 and NPM1 Are Powerful Determinants of Outcome in Acute Myeloid Leukemia Patients Treated with Autologous Stem Cell Transplantation: An Analysis By the Acute Leukemia Working Party of the EBMT

Permissive HLA-DPB1 Mismatch and Survival after Unrelated Donor Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Comparative Analysis of Different Immunogenetic Models on 422 Patients from GITMO and IBMDR

Outcomes of Graft Failures after Umbilical Cord Blood Transplantation in Acute Leukemia: A Study from Eurocord and the Acute Leukemia Working Party of the EBMT

Impact of CTLA4 genotype and other immune response gene polymorphisms on outcomes after single umbilical cord blood transplantation

Impact of CTLA4 Genotype and Other Immune Response Gene Polymorphisms on Outcomes after Umbilical Cord Blood Transplantation - a Eurocord, CBC-Ctiwb-EBMT, Netcord and FMRP-USP Study

Flow Cytometry Assessment of CD34 + Viability in Thawed Cord Blood Units: A Multi-Center Eurocord and Netcord Study

Fully Automated Washing of Cryopreserved Peripheral Blood Stem Cells (PBSC): Results of a Prospective, Multicenter, Clinical Trial.

Autologous Hematopoietic Stem Cell Transplantation Versus Intravenous Pulse Therapy Cyclophosphamide for Severe or Rapidly Progressive Systemic Sclerosis, the Astis Trial

Determining Late Engraftment Following Single Cord, Unrelated Transplantation: An Analysis of the Eurocord Registry

Autologous Hematopotoietic Stem Cell Transplantation in Multiple Sclerosis with An Intermediate Intensity Conditioning Regimen: The Italian Multi-Centre Experience

Endothelial progenitor cell–dependent angiogenesis requires localization of the full-length form of uPAR in caveolae

Dendritic cells with lymphocyte-stimulating activity differentiate from human CD133 positive precursors

Prophylaxis and Treatment of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation: A Survey on Center Strategies by the European Group for Blood and Marrow Transplantation (EBMT)

Cytomegalovirus (CMV) and Epstein-Barr Virus (EBV) Reactivation In Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Severe Multiple Sclerosis (MS).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only